Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
about
A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGDStepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicinA tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis.NIR-Laser-Controlled Drug Release from DOX/IR-780-Loaded Temperature-Sensitive-Liposomes for Chemo-Photothermal Synergistic Tumor Therapy.Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatmentRedefining the role(s) of endothelial αvβ3-integrin in angiogenesis.Preclinical studies of dendrimer prodrugs.NRP1 transport of cancer therapeutics mediated by tumor-penetrating peptides.Well-defined hydroxyethyl starch-10-hydroxy camptothecin super macromolecule conjugate: cytotoxicity, pharmacodynamics research, tissue distribution test and intravenous injection safety assessment.A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs.Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy.Nano-based delivery of RNAi in cancer therapy.Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.RGD Peptide-Based Target Drug Delivery of Doxorubicin Nanomedicine.iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy.Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer.Passive tumour targeting and extravasation of cylindrical polymer brushes in mouse xenografts.Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo.Indocyanine green-incorporating nanoparticles for cancer theranostics.Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.Dendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful NanomedicineProgrammable Biopolymers for Advancing Biomedical Applications of Fluorescent Nanodiamonds
P2860
Q28548244-FF17660A-91F5-4A8E-A5BC-1A2D28E99AB5Q33807144-E055373D-8DCA-4BA1-A780-D49042F27F94Q35868066-A0AB9E96-3BAB-434C-B666-83D49EE15938Q36201759-7DB24C87-663D-4A09-82E5-C4F190CEAB0CQ36454892-86D8A37F-6784-4503-851F-CFFCC6DDA1D5Q36544942-F2FEB8AB-4CE6-4136-A058-CB730E3F7490Q38268451-D26F377A-53AE-402D-93A2-005CEF125F76Q38509638-021DA9CE-9F56-4327-9CE4-3A40D0A6127CQ38672213-AD49C746-8684-4946-A130-9E0F9A5CAD6BQ38797396-ECFF4CBA-ED4F-44C6-A290-0F9A1A0C659FQ38842975-ADEECCEB-F1B5-40FA-A14B-1E6398D1922FQ39103231-46873029-652D-476A-B145-8BECCBB903A5Q41734074-511D419D-4DFD-4164-9C6D-8210707AD36FQ42339315-7F2E8E50-400C-40DC-B260-676588418383Q46039070-4EB687B8-64CE-45DA-B7CB-3B92B56862BCQ46505275-43FEFF8E-D64A-4145-9F67-801BD78D1EF7Q46507854-E41A8601-F25B-442D-AA3A-7398FA4B9EA4Q47815925-E2D3460D-2768-47E2-9E4F-31B07A13A25FQ48504707-BD601437-361D-4EDC-A1A6-81B52DED9561Q48658092-0A732528-E979-40E2-A76C-8BBE74C67239Q48748364-B0C17989-2F4C-4C53-B351-8C616FB8E0ECQ52653896-9EDAE9CC-EAC3-4AED-8630-A2633CDF9574Q52673018-BDCE4B0C-75BC-454B-82A4-489962E2C9B7Q55431512-0AA69C19-18E1-4C9D-9419-51A4E758CC9BQ57556323-DE0CAEE8-E96A-4CEA-A3E4-A8B482361606Q58202906-DC9E32E8-ADBF-4A02-BB86-890C7B7AC613
P2860
Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Tumor penetrability and anti-a ...... oxorubicin-polymer conjugates.
@en
type
label
Tumor penetrability and anti-a ...... oxorubicin-polymer conjugates.
@en
prefLabel
Tumor penetrability and anti-a ...... oxorubicin-polymer conjugates.
@en
P2093
P1433
P1476
Tumor penetrability and anti-a ...... oxorubicin-polymer conjugates.
@en
P2093
Baohong Jiang
Xiaofeng Zhang
Yanyan Jiang
P304
P356
10.1016/J.BIOMATERIALS.2014.06.042
P577
2014-07-11T00:00:00Z